Mrs. Catherine Felicity Ruiz, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 275 W Dundee Rd, Buffalo Grove, IL 60089 Phone: 847-777-8995 |
Krista Hoge Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Mchenry Rd, Buffalo Grove, IL 60089 Phone: 847-537-5000 |
Person Centered Senior Solutions Occupational Therapist - Gerontology Medicare: Medicare Enrolled Practice Location: 1513 Anderson Ln, Buffalo Grove, IL 60089 Phone: 847-495-8313 |
Dr. Raena N Bennett, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1371 Abbott Ct, Buffalo Grove, IL 60089 Phone: 847-777-8995 |
Megan E Albert, MSOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1371 Abbott Ct Ste A, Buffalo Grove, IL 60089 Phone: 847-777-8995 |
Mrs. Bonnie Ilene Yassinger, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 N Welland Road, Buffalo Grove, IL 60089 Phone: 847-465-0200 |
Alexa Akana Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 500 Mchenry Rd, Buffalo Grove, IL 60089 Phone: 773-450-1450 |
Samantha Irene Sisto Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 333 W Dundee Rd, Buffalo Grove, IL 60089 Phone: 847-777-8955 |
Khusbu Sheth Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1131 Mchenry Rd Ste 107a, Buffalo Grove, IL 60089 Phone: 847-305-1097 |
Melissa Vaughan Umansky, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 275 W Dundee Rd, Buffalo Grove, IL 60089 Phone: 847-777-8995 |
Melissa Arlene Donegan, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 275 W Dundee Rd, Buffalo Grove, IL 60089 Phone: 847-777-8995 |
Vincent Casali, MOT OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 275 W Dundee Rd, Buffalo Grove, IL 60089 Phone: 847-777-8995 |
Emma Lee Williams, COTA/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 275 W Dundee Rd, Buffalo Grove, IL 60089 Phone: 847-777-8995 |
Nimra Burney Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 275 W Dundee Rd, Buffalo Grove, IL 60089 Phone: 847-777-8995 |
Rachel Susan Johnson Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 275 W Dundee Rd, Buffalo Grove, IL 60089 Phone: 847-777-8995 |
Claire Elizabeth Hadley Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 275 W Dundee Rd, Buffalo Grove, IL 60089 Phone: 847-777-8995 |
Taylor Coblentz Occupational Therapist Medicare: Medicare Enrolled Practice Location: 500 Mchenry Rd, Buffalo Grove, IL 60089 Phone: 847-532-3492 |
M Bill Hellyer, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 601 Deerfield Pkwy, Buffalo Grove, IL 60089 Phone: 224-513-6466 |
Dr. Moira Priven Bushell, OTD, MED, OTR/L, BCP Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 116 Copperwood Dr, Buffalo Grove, IL 60089 Phone: 516-241-0430 |
Elena Presta, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1371 Abbott Ct, Buffalo Grove, IL 60089 Phone: 847-777-8995 |
News Archive
Alexion Pharmaceuticals, Inc. has announced today that SolirisĀ® (eculizumab), its first-in-class complement inhibitor, has been granted Orphan Medicinal Product Designation by the European Commission for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). AHUS is an ultra-rare, inherited, and life-threatening complement-inhibitor deficiency disease that often progresses to end-stage kidney disease or failure. The U.S. Food and Drug Administration granted orphan drug designation to Soliris for the same indication in May 2009. Soliris is not approved for the treatment of patients with aHUS.
Researchers examined healthy food availability and diet quality among Baltimore City and Baltimore County, Md., residents and found that availability of healthy foods was associated with quality of diet and 46 percent of lower-income neighborhoods had a low availability of healthy foods.
MIT chemical engineers have developed a new sensor that lets them see inside cancer cells and determine whether the cells are responding to a particular type of chemotherapy drug.
ZymoGenetics, Inc. today announced positive results from a Phase 2 clinical trial in metastatic melanoma with recombinant Interleukin 21 (IL-21) as a single agent. The trial met the primary endpoint of efficacy, as measured by objective response rate or lack of early disease progression. Overall response rate was 23.1%, in evaluable patients, and median progression-free survival was 4.3 months. The results were presented at the American Society of Clinical Oncology meeting.
› Verified 2 days ago